It has been shown that tumor-to-spleen uptake ratio for 111In and 68Ga-labeled affibody molecules [40] and tumor-to-contralateral breast ratio for 99mTc-labeled ADAPT6 [41] correlates strongly with the level of HER2 expression in breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.